摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(R)-3-(tert-butyldimethylsilyloxy)dodecanal | 913655-51-3

中文名称
——
中文别名
——
英文名称
(R)-3-(tert-butyldimethylsilyloxy)dodecanal
英文别名
(3R)-3-[tert-butyl(dimethyl)silyl]oxydodecanal
(R)-3-(tert-butyldimethylsilyloxy)dodecanal化学式
CAS
913655-51-3
化学式
C18H38O2Si
mdl
——
分子量
314.584
InChiKey
GZONIKUYHKMSCF-QGZVFWFLSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    6.11
  • 重原子数:
    21
  • 可旋转键数:
    13
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.94
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (R)-3-(tert-butyldimethylsilyloxy)dodecanal偶氮二甲酸二苄酯L-脯氨酸 、 sodium tetrahydroborate 作用下, 以 乙腈乙醇 为溶剂, 反应 2.08h, 以803 mg的产率得到(2S,3R)-2-(N,N'-bis(benzyloxycarbonyl)hydrazino)-3-(tert-butyldimethylsilyloxy)dodecanol
    参考文献:
    名称:
    Sphinganine和Clavaminol H的不对称合成
    摘要:
    报道了一种有效的对映体选择性合成斯潘加宁和卡瓦米酚H的方法。这些鞘氨醇型碱是通过使用高度对映选择性的Ru催化的氢化反应和有机催化的亲电胺化反应从立体异构中心获得的,可从市售脂肪酸中获得。
    DOI:
    10.1021/jo1003899
  • 作为产物:
    参考文献:
    名称:
    Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative:  Inhibitors of Fatty Acid Synthase
    摘要:
    Concise syntheses of orlistat ( Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.
    DOI:
    10.1021/ol061651o
点击查看最新优质反应信息

文献信息

  • BETA-LACTONE COMPOUNDS
    申请人:Smith Jeffrey W.
    公开号:US20090124681A1
    公开(公告)日:2009-05-14
    The present invention provides compounds having the general structure A, or a pharmaceutically acceptable derivatives thereof: wherein R is an alkyl group, and R 1 comprises at least one moiety selected from a group consisting of an alkyl, an alkenyl, an aryl, a heterocycle, hydroxyl, ester, amido, aldehyde, and a halogen.
    本发明提供具有一般结构A的化合物,或其药学上可接受的衍生物:其中R是烷基基团,R1包括至少一种从烷基、烯基、芳基、杂环、羟基、酯、酰胺、醛基和卤素组成的基团。
  • Synthesis of Novel β-Lactone Inhibitors of Fatty Acid Synthase
    作者:Robyn D. Richardson、Gil Ma、Yatsandra Oyola、Manuel Zancanella、Lynn M. Knowles、Piotr Cieplak、Daniel Romo、Jeffrey W. Smith
    DOI:10.1021/jm800321h
    日期:2008.9.11
    Fatty acid synthase (FAS) is necessary for growth and survival of tumor cells and is a promising drug target for oncology. Here, we report oil the syntheses and activity of novel inhibitors of the thioesterase domain of FAS. Using the structure of orlistat as a starting point, which contains a beta-lactone as the central pharmacophore, 28 novel congeners were synthesized and examined. Structural features such as the length of the alpha- and beta-alkyl chains, their chemical composition, and arnino ester substitutions were altered and tile resulting compounds explored for inhibitory activity toward the thioesterase domain of FAS. Nineteen congeners show improved potency for FAS in biochemical assays relative to orlistat. Three of that subset, including the natural product valilactone, also display all increased potency in inducing tumor cell death and improved solubility compared to orlistat. These findings Support the idea that all orlistat congener can be optimized for use in a preclinical drug design and for clinical drug development.
  • Asymmetric Synthesis of Sphinganine and Clavaminol H
    作者:Ramzi Ait-Youcef、Xavier Moreau、Christine Greck
    DOI:10.1021/jo1003899
    日期:2010.8.6
    An efficient enantioselective synthesis of sphinganine and clavaminol H is reported. These sphingoid-type bases were obtained from commercially available fatty acids using highly enantioselective Ru-catalyzed hydrogenation and organocatalytic electrophilic amination reactions to create the stereogenic centers.
    报道了一种有效的对映体选择性合成斯潘加宁和卡瓦米酚H的方法。这些鞘氨醇型碱是通过使用高度对映选择性的Ru催化的氢化反应和有机催化的亲电胺化反应从立体异构中心获得的,可从市售脂肪酸中获得。
  • Total Synthesis and Comparative Analysis of Orlistat, Valilactone, and a Transposed Orlistat Derivative:  Inhibitors of Fatty Acid Synthase
    作者:Gil Ma、Manuel Zancanella、Yatsandra Oyola、Robyn D. Richardson、Jeffrey W. Smith、Daniel Romo
    DOI:10.1021/ol061651o
    日期:2006.9.1
    Concise syntheses of orlistat ( Xenical), a two-carbon transposed orlistat derivative, and valilactone are described that employ the tandem Mukaiyama aldol-lactonization (TMAL) process as a key step. This process allows facile modification of the alpha-side chain. Versatile strategies for modifying the delta-side chain are described, involving cuprate addition and olefin metathesis. Comparative antagonistic activity of these derivatives toward a recombinant form of the thioesterase domain of fatty acid synthase is reported along with comparative activity-based profiling.
查看更多

同类化合物

(2-溴乙氧基)-特丁基二甲基硅烷 骨化醇杂质DCP 马来酸双(三甲硅烷)酯 顺式-二氯二(二甲基硒醚)铂(II) 顺-N-(1-(2-乙氧基乙基)-3-甲基-4-哌啶基)-N-苯基苯酰胺 降钙素杂质13 降冰片烯基乙基三甲氧基硅烷 降冰片烯基乙基-POSS 间-氨基苯基三甲氧基硅烷 镁,氯[[二甲基(1-甲基乙氧基)甲硅烷基]甲基]- 锑,二溴三丁基- 铷,[三(三甲基甲硅烷基)甲基]- 铂(0)-1,3-二乙烯-1,1,3,3-四甲基二硅氧烷 钾(4-{[二甲基(2-甲基-2-丙基)硅烷基]氧基}-1-丁炔-1-基)(三氟)硼酸酯(1-) 金刚烷基乙基三氯硅烷 辛醛,8-[[(1,1-二甲基乙基)二甲基甲硅烷基]氧代]- 辛甲基-1,4-二氧杂-2,3,5,6-四硅杂环己烷 辛基铵甲烷砷酸盐 辛基衍生化硅胶(C8)ZORBAX?LP100/40C8 辛基硅三醇 辛基甲基二乙氧基硅烷 辛基三甲氧基硅烷 辛基三氯硅烷 辛基(三苯基)硅烷 辛乙基三硅氧烷 路易氏剂-3 路易氏剂-2 路易士剂 试剂3-[Tris(trimethylsiloxy)silyl]propylvinylcarbamate 试剂2-(Trimethylsilyl)cyclopent-2-en-1-one 试剂11-Azidoundecyltriethoxysilane 西甲硅油杂质14 衣康酸二(三甲基硅基)酯 苯胺,4-[2-(三乙氧基甲硅烷基)乙基]- 苯磺酸,羟基-,盐,单钠聚合甲醛,1,3,5-三嗪-2,4,6-三胺和脲 苯甲醇,a-[(三苯代甲硅烷基)甲基]- 苯基二甲基氯硅烷 苯基二甲基乙氧基硅 苯基乙酰氧基三甲基硅烷 苯基三辛基硅烷 苯基三甲氧基硅烷 苯基三乙氧基硅烷 苯基三丁酮肟基硅烷 苯基三(异丙烯氧基)硅烷 苯基三(2,2,2-三氟乙氧基)硅烷 苯基(3-氯丙基)二氯硅烷 苯基(1-哌啶基)甲硫酮 苯乙基三苯基硅烷 苯丙基乙基聚甲基硅氧烷 苯-1,3,5-三基三(三甲基硅烷)